Clinical Trials Logo

Promyelocytic Leukemia, Acute clinical trials

View clinical trials related to Promyelocytic Leukemia, Acute.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04562818 Completed - Clinical trials for Promyelocytic Leukemia, Acute

Results From a Mexican Acute Promyelocytic Leukemia.

Mexico APL
Start date: January 1, 2007
Phase:
Study type: Observational

Retrospective, observational study, comparing treatments of acute promyelocytic leukemia in different centers in México. There is no sufficient information about acute promyelocytic leukemia in America Latina, particularly in Mexico. For these reason the investigators started a study adding all promyelocityc patients from the main Hospital in Mexico in order to put together a group of patient and analyze the response, overall survival and what are the characteristics of the population. The investigators included 5 Hospital in Mexico City and states as Monterrey, Guadalajara, San Luis Potosi, Puebla, Veracruz, Yucatán, Oaxaca, Guanajuato, Estado de México. Even do, the investigators didn´t have arsenic trioxide they are treating patients with standard chemotherapy. These paper will help to show the authorities that the cost of treating patient with standard chemotherapy is much more higher than ATO-ATRA. The investigators are now doing a cost benefit analysis so the investigators, can soon have ATO treatment as standard of care in Mexico for the treatment of acute promyelocytic leukemia.